Patents Assigned to Merial LLC
  • Patent number: 6645740
    Abstract: The invention relates to the equine GM-CSF, its nucleotide coding sequence and its amino acid sequence, as well as its use as adjuvant in equine vaccination and as non-specific immunity stimulant. The invention also includes compositions containing equine GM-CSF or vectors expressing GM-CSF in vivo.
    Type: Grant
    Filed: June 7, 2000
    Date of Patent: November 11, 2003
    Assignees: Merial Limited, Merial LLC
    Inventors: Michel Bublot, Jennifer Maria Perez, Christine Michèle Pierrette Andreoni
  • Patent number: 6174540
    Abstract: Long-acting injectable formulations are formed from a) a therapeutic agent selected from insecticides, acaricides, parasiticides, growth enhancers or oil-soluble NSAIDs, b) hydrogenated castor oil, and c) a hydrophobic carrier comprising i) triacetin, benzyl benzoate, ethyl oleate, or a combination thereof, and ii) acylated monoglycerides, propyl dicaprylates/dicaprates, caprylic/capric acid triglycerides or a combination thereof.
    Type: Grant
    Filed: September 14, 1998
    Date of Patent: January 16, 2001
    Assignees: Merck & Co., Inc., Merial LLC
    Inventors: James B. Williams, Rey T. Chern